Sangamo Therapeutics
SGMO
SGMO
222 hedge funds and large institutions have $1.22B invested in Sangamo Therapeutics in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 69 increasing their positions, 71 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 71
2.55% less ownership
Funds ownership: 57.9% → 55.35% (-2.6%)
Holders
222
Holding in Top 10
1
Calls
$40.5M
Puts
$22.4M
Top Buyers
| 1 | +$46.2M | |
| 2 | +$12.5M | |
| 3 | +$9.89M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$9.19M |
| 5 |
Morgan Stanley
New York
|
+$7.48M |
Top Sellers
| 1 | -$36.4M | |
| 2 | -$15M | |
| 3 | -$14.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$11.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$10.1M |